Shenkman Capital Management Inc has filed its 13F form on February 10, 2025 for Q4 2024 where it was disclosed a total value porftolio of $46 Million distributed in 99 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Invesco ETF Tr Ii Sr Ln ETF with a value of $22.7M, Lending Tree, Inc. with a value of $14.8M, Clear Channel Outdoor Holdings, Inc. with a value of $4.05M, Ishares Tr Broad Usd High Yiel with a value of $2.68M, and Spdr Bloomberg Short Term High with a value of $1.06M.
Examining the 13F form we can see an decrease of $90M in the current position value, from $136M to 46M .
Shenkman Capital Management Inc is based out at New York, NY
Below you can find more details about Shenkman Capital Management Inc portfolio as well as his latest detailed transactions.
Portfolio value
$46 Million
ETFs: $26.4 Million
Financial Services: $14.8 Million
Communication Services: $4.05 Million
Consumer Cyclical: $707,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q4 2024
Added 20.25%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 29.14%
-
$0
0.0% of portfolio
-
Q4 2024
Added 14.27%
-
$0
0.0% of portfolio
-
Q4 2024
Added 8.24%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 98.34%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 3.39%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 41.05%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 85.73%
-
$0
0.0% of portfolio
-
Q4 2024
Added 23.78%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 20.0%
-
$0
0.0% of portfolio
-
Q4 2024
Added 21.25%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 98.19%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 52.63%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.42%
-
$0
0.0% of portfolio
-
Q4 2024
Added 772.05%
-
$0
0.0% of portfolio
-
Q4 2024
Added 6.01%
-
$0
0.0% of portfolio
-
Q4 2024
Added 13.48%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
Added 11.36%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 42.35%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 47.76%
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q4 2024
Added 39.78%
-
$0
0.0% of portfolio
-
Q4 2024
Added 521.0%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 83.61%
-
$0
0.0% of portfolio
-
Q4 2024
Added 208.77%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 48.1%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 27.83%
-
$0
0.0% of portfolio
-
Q4 2024
Added 38.8%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 70.74%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q4 2024
Added 114.54%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 99.06%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 6.25%
-
$0
0.0% of portfolio
-
Q4 2024
Added 5.14%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
Added 259.82%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 99.77%
-
$0
0.0% of portfolio
-
Q4 2024
Added 23.64%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 95.86%
-
$0
0.0% of portfolio
-
Q4 2024
Added 18.78%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 2.22%
-
$0
0.0% of portfolio
-
Q4 2024
Added 37.09%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
Envista Holdings Corporation
-
$0
0.0% of portfolio
-
Q4 2024
Added 31.77%
-
$0
0.0% of portfolio
-
Q4 2024
Added 17.31%
-
$0
0.0% of portfolio
-
Q4 2024
Added 20.0%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.89%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 11.73%
-
$0
0.0% of portfolio
-
Q4 2024
Added 2.67%
-
$0
0.0% of portfolio
-
Q4 2024
Added 39.52%